ANX-514: Submit IND

Next quarter, ANX will submit an IND to begin a bioequivalence trial in 28 patients to compare ANX-514 vs. Taxotere docetaxel from sanofi-aventis Group (Euronext:SAN; SNY, Paris, France). ...